Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trial. - Houser KV; Gaudinski MR; Happe M; Narpala S; Verardi R; Sarfo EK; Corrigan AR; Wu R; Rothwell RS; Novik L; Hendel CS; Gordon IJ; et al. (EClinicalMedicine, 2022)